The study described in this report established the critical role of HK2 overexpression in resistance to GEM‐induced cell apoptosis and elucidated the underlying mechanism in pancreatic cancer, which demonstrated that HK2 deletion increases sensitivity to GEM therapy. Here, HK2 is linked to familial pancreatic carcinoma.